A PHASE II OPEN-LABEL STUDY OF UM171-EXPANDED CORD BLOOD TRANSPLANTATION IN PATIENTS WITH HIGH AND VERY HIGH-RISK ACUTE LEUKEMIA/MYELODYSPLASIA.
Primary Objective
- Examine the safety (including assessment of rate of graft failure) and feasibility of infusing a single ECT-001-expanded cord blood in patients with high and very high-risk acute leukemia/myelodysplasia -Evaluate relapse free survival at 1- and 2-years post-transplant in a group of patients with high risk acute leukemia/myelodysplasia
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Jonathan Gutman, MD
Study ID
Protocol Number: 20-3031
More information available at ClinicalTrials.gov: NCT04103879
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers